Uric acid shows potential as new stroke treatment in preclinical study
In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The ...
News-Medical.Net15h
Study shows potential of uric acid as add-on therapy for stroke
In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The findings suggest that the treatment may work as an add-on therapy to standard ...
Mirage News16h
NIH Study Finds Potential New Stroke Treatment
In a preclinical study, rodents treated with uric acid showed improved long-term outcomes after acute ischemic stroke. The ...
Zacks Small Cap Research on MSN17h
NRXBF Test Results Bolster Prospects
NRXBF READ THE FULL NRXBF RESEARCH REPORT NurExone (OTC:NRXBF) is developing a product known as ExoPTEN that is designed to treat patients with acute spinal cord injuries, while also conducting ...
Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System
Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System ...
Ophthalmology Times19h
Preclinical study of KIO-104 in a proliferative vitreoretinopathy model accepted for poster presentation at ARVO 2025
The findings of this model support KIO-104 as a promising therapeutic candidate for both the prevention and treatment of PVR.